Thyroid Cancer New Drug: Selpercatinib in RET-mutant Medullary Thyroid Cancer Ulas D. Bayraktar, MD 2023-11-20
Non-Small Cell Lung Cancer New Drug: Selpercatinib in RET-Fusion Positive NSCLC Ulas D. Bayraktar, MD 2022-11-26
